Pfizer revenue by segment 2017-2019

This statistic depicts revenues of pharmaceutical company Pfizer from 2017 to 2019, by segment. Pfizer Inc. is a multinational pharmaceutical corporation. The company is headquartered in Midtown Manhattan, New York City. In 2019, Pfizer's Biopharma (IH) segment generated some 39.4 billion U.S. dollars of revenue. Pfizer is the world's largest company based on pure pharmaceutical revenue. Due to the Upjohn spin-off during 2020 and the Consumer Healthcare business merger with GSK's consumer health segment to a joint venturre in 2019, only the Biopharma segment remained.

Pfizer's revenue from 2017 to 2019, by segment* (in million U.S. dollars)

Characteristic	Biopharma	Upjohn	Consumer Healthcare
2017	35,530	13,447	3,472
2018	37,558	12,484	3,605
2019	39,419	10,233	2,098

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2020

More information

Region

Worldwide

Survey time period

2017 to 2019

Supplementary notes

* Does not include other business activities and reconciling items. This statistic will not be updated due to Pfizer's business reorganization in 2019 and 2020.

Citation formats